Ragab, M., Wieland, J., Ávila de Melo, C. W., Agibalova, T., Ermolova, A., Durner, N., Hempel, A., Heindl, F., Maurer, H. C., Steiger, K., Janssen, K.-P., Tschurtschenthaler, M., Wang, T. C., Quante, M., Schmid, R. M., & Middelhoff, M. (2025). Epithelial Genetic Muscarinic Receptor 3 Ablation Induces Sex-Specific Modulation of Colonic Intestinal Progenitor Cells and Response to Intestinal Injury. Journal of Crohn’s and Colitis. https://doi.org/10.1093/ecco-jcc/jjaf038

Sun, J., Yao, J., Olén, O., Halfvarsson, J., Bergman, D., Ebrahimi, F., Carlsson, S., Ludvigsson, J., & Ludvigsson, J. F. (2024). Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control study. The Lancet Regional Health - Europe, 46, 101056. https://doi.org/10.1016/j.lanepe.2024.101056

Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024). Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European Heart Journal, 45(28), 2493–2504. https://doi.org/10.1093/eurheartj/ehae338

Shepherd, A., Feinstein, L., Sabel, S., Rastelli, D., Mezhibovsky, E., Matthews, L., Muppirala, A., Robinson, A., Sharma, K. R., ElSeht, A., Zeve, D., Breault, D. T., Gershon, M. D., & Rao, M. (2024). RET Signaling Persists in the Adult Intestine and Stimulates Motility by Limiting PYY Release From Enteroendocrine Cells. Gastroenterology, 166(3), 437–449. https://doi.org/10.1053/j.gastro.2023.11.020

Mullish, B. H., Michael, D. R., Dabcheva, M., Webberley, T. S., Coates, N., John, D. A., Wang, D., Luo, Y., Plummer, S. F., & Marchesi, J. R. (2024). A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females. Neurogastroenterology & Motility, 36(4). Portico. https://doi.org/10.1111/nmo.14751

Garretti, F., Monahan, C., Sloan, N., Bergen, J., Shahriar, S., Kim, S. W., Sette, A., Cutforth, T., Kanter, E., Agalliu, D., & Sulzer, D. (2023). Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease. Neuron, 111(21), 3397-3413.e5. https://doi.org/10.1016/j.neuron.2023.07.015

Blackett, J. W., Elkind, M. S. V., O’Byrne, S., Wainberg, M., Purpura, L., Chang, L., & Freedberg, D. E. (2023). Sadness and Anxiety Modify the Relationship Between COVID-19 and Gastrointestinal Symptoms at 6–12 Months of Follow-up. Gastro Hep Advances, 2(7), 918–924. https://doi.org/10.1016/j.gastha.2023.06.006

Malick, A., Wang, Y., Axelrad, J., Salmasian, H., & Freedberg, D. (2022). Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection. Gut Pathogens, 14(1). https://doi.org/10.1186/s13099-022-00479-z

Gomez-Simmonds, A., Annavajhala, M. K., Nunez, M. P., Macesic, N., Park, H., & Uhlemann, A.-C. (2022). Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients. MSphere, 7(5). https://doi.org/10.1128/msphere.00361-22

Blackett, J. W., Sun, Y., Purpura, L., Margolis, K. G., Elkind, M. S. V., O’Byrne, S., Wainberg, M., Abrams, J. A., Wang, H. H., Chang, L., & Freedberg, D. E. (2022). DECREASED GUT MICROBIOME TRYPTOPHAN METABOLISM AND SEROTONERGIC SIGNALING IN PATIENTS WITH PERSISTENT MENTAL HEALTH AND GASTROINTESTINAL SYMPTOMS AFTER COVID-19. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000524